Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
CRISPR–Cas systems eliminate nucleic acid invaders in bacteria and archaea. The effector complex of the Type III-B Cmr system cleaves invader RNAs recognized by the CRISPR RNA (crRNA ) of the complex. Here we show that invader RNAs also activate the Cmr complex to cleave DNA. As has been observed for other Type III systems, Cmr eliminates plasmid invaders in Pyrococcus furiosus by a mechanism that depends on transcription of the crRNA target sequence within the plasmid. Notably, we found that the target RNA per se induces DNA cleavage by the Cmr complex in vitro. DNA cleavage activity does not depend on cleavage of the target RNA but notably does require the presence of a short sequence adjacent to the target sequence within the activating target RNA (rPAM [RNA protospacer-adjacent motif]). The activated complex does not require a target sequence (or a PAM) in the DNA substrate. Plasmid elimination by the P. furiosus Cmr system also does not require the Csx1 (CRISPR-associated Rossman fold [CARF] superfamily) protein. Plasmid silencing depends on the HD nuclease and Palm domains of the Cmr2 (Cas10 superfamily) protein. The results establish the Cmr complex as a novel DNA nuclease activated by invader RNAs containing a crRNA target sequence and a rPAM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031 · cited 7×
“…in the limitation of DNA nuclease activity Cleavage of invader RNAs (complementary to the crRNA) has been observed for numerous Type III systems (Hale et al. 2009; Zhang et al. 2012; Staals et al. 2013, 2014; Tamulaitis et al. 2014; Samai et al. 2015) and, prior to detection of DNA nuclease…”
BackgroundMethodInfluentialSelf-citationArchaeal CRISPR-based immune systems: exchangeable functional modules
Garrett, R. A., Vestergaard, G., & Shah, S. A. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.08.002 · Cited by 98
Cited by
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
The Biology of CRISPR-Cas: Backward and Forward
Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018) · Cell · doi:10.1016/j.cell.2017.11.032 · Cited by 1,039
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & van der Oost, J. (2016) · Science · doi:10.1126/science.aad5147 · Cited by 671
A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G., & Siksnys, V. (2017) · Science · doi:10.1126/science.aao0100 · Cited by 521
Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
Niewoehner, O., Garcia-Doval, C., Rostøl, J. T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L. A., & Jinek, M. (2017) · Nature · doi:10.1038/nature23467 · Cited by 509
Evolutionary Genomics of Defense Systems in Archaea and Bacteria
Koonin, E. V., Makarova, K. S., & Wolf, Y. I. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093830 · Cited by 348
CRISPR technologies and the search for the PAM-free nuclease
Collias, D., & Beisel, C. L. (2021) · Nature Communications · doi:10.1038/s41467-020-20633-y · Cited by 304
Recruitment of CRISPR-Cas systems by Tn7-like transposons
Peters, J. E., Makarova, K. S., Shmakov, S., & Koonin, E. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1709035114 · Cited by 292
PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
Gleditzsch, D., Pausch, P., Müller-Esparza, H., Özcan, A., Guo, X., Bange, G., & Randau, L. (2019) · RNA Biology · doi:10.1080/15476286.2018.1504546 · Cited by 280
Kazlauskiene, M., Tamulaitis, G., Kostiuk, G., Venclovas, Č., & Siksnys, V. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.024 · Cited by 265
Molecular mechanisms of CRISPR–Cas spacer acquisition
McGinn, J., & Marraffini, L. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0071-7 · Cited by 262
Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back
Koonin, E. V., & Makarova, K. S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx192 · Cited by 176
CRISPR-Based Technologies: Impact of RNA-Targeting Systems
Terns, M. P. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.018 · Cited by 168
Self-citationAdvances in CRISPR-Cas systems for RNA targeting, tracking and editing
Wang, F., Wang, L., Zou, X., Duan, S., Li, Z., Deng, Z., Luo, J., Lee, S. Y., & Chen, S. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.016 · Cited by 128
Type III CRISPR-Cas immunity: major differences brushed aside
Tamulaitis, G., Venclovas, Č., & Siksnys, V. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.012 · Cited by 126
RNA-Targeting CRISPR-Cas systems and their applications
Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031122 · Cited by 125
Structural basis of CRISPR-Cas Type III prokaryotic defence systems
Molina, R., Sofos, N., & Montoya, G. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.06.010 · Cited by 48
RNA targeting and cleavage by the type III-Dv CRISPR effector complex
Schwartz, E. A., Bravo, J. P. K., Ahsan, M., Macias, L. A., McCafferty, C. L., Dangerfield, T. L., Walker, J. N., Brodbelt, J. S., Palermo, G., Fineran, P. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47506-y · Cited by 30
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23
Grüschow, S., McQuarrie, S., Ackermann, K., McMahon, S., Bode, B. E., Gloster, T. M., & White, M. F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae167 · Cited by 25
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23
(2023) · doi:10.1101/2023.11.24.568546 · Cited by 25
Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA
Goswami, H. N., Rai, J., Das, A., & Li, H. (2022) · eLife · doi:10.7554/elife.81678 · Cited by 20
Self-citationGuo, T., Zheng, F., Zeng, Z., Yang, Y., Li, Q., She, Q., & Han, W. (2019) · RNA Biology · doi:10.1080/15476286.2019.1642725 · Cited by 11
Metadata
- Authors
- Elmore, J. R., Sheppard, N. F., Ramia, N., Deighan, T., Li, H., Terns, R. M., & Terns, M. P.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-02-04
- Volume
- 30
- Issue
- 4
- Pages
- 447-459
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2252611736
- Cited by
- 218
- References
- 4
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.